CCR5 and systemic sclerosis: Indeed, the endothelium damage promoted by inflammatory mediators (IL‐6, TNF‐α, IL‐1β, and CCR5) and the progressive fibrotic process may contribute to cerebrovascular events observed in patients with SSc.